| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 05/25/2011 | CN102068639A Externally traditional Chinese medicine for treating pustulosis |
| 05/25/2011 | CN102068632A Chinese medicinal formula for treating acute appendicitis |
| 05/25/2011 | CN102068621A Chinese medicinal composition for treating infantile cold and fever and preparation method thereof |
| 05/25/2011 | CN102068620A Traditional Chinese medicine composition for treatment of infant cold and fever and preparation method thereof |
| 05/25/2011 | CN102068619A Chinese medicinal composition for treating infant cold and fever and preparation method thereof |
| 05/25/2011 | CN102068617A Pure Chinese herbal medicine inflammation-diminishing and sterilizing suspension liniment and preparation method thereof |
| 05/25/2011 | CN102068611A Externally applied medicine for treating acute herpes |
| 05/25/2011 | CN102068543A Chinese medicinal composition for treating suppurative otitis media |
| 05/25/2011 | CN102068536A Compound Chinese medicinal particles and application thereof to preparation of medicament for preventing and treating pig digestive tract disease |
| 05/25/2011 | CN102068508A Chinese medicinal lotion for treating beriberi |
| 05/25/2011 | CN102068506A Sterilizing and antimicrobial Chinese medicinal disinfectant |
| 05/25/2011 | CN102068492A Anti-virus Chinese herbal medicine composition, traditional Chinese medicine composition and preparation method thereof |
| 05/25/2011 | CN102068480A Edible and medicinal compound preparation with effects of heatstroke alleviation and detoxification |
| 05/25/2011 | CN102068479A Chinese medicinal composition for treating chronic urinary tract infection and preparation method thereof |
| 05/25/2011 | CN102068473A Novel medicinal composition, preparation method, preparation and application thereof |
| 05/25/2011 | CN102068464A Antibacterial and antiviral effective part extract of medicated leaven and medicinal use thereof |
| 05/25/2011 | CN102068461A Chinese medicinal composition for treating sores and erythra |
| 05/25/2011 | CN102068452A Antiviral medicinal composition |
| 05/25/2011 | CN102068451A Ointment for treating acne and preparation method thereof |
| 05/25/2011 | CN102068447A Application of triterpenoid saponin compound in preparation of medicaments for treating autoimmune diseases |
| 05/25/2011 | CN102068446A Application of triterpenoid saponin compound to preparation of anti-pathogeny microorganism medicament |
| 05/25/2011 | CN102068444A Ointment for treating skin diseases |
| 05/25/2011 | CN102068443A Compound florfenicol preparation for aquatic products and preparation method and application thereof |
| 05/25/2011 | CN102068442A Prescription for preventing white-spot disease of turtles |
| 05/25/2011 | CN102068437A Antibacterial composition |
| 05/25/2011 | CN102068425A Improved oseltamivir phosphate medicinal composition |
| 05/25/2011 | CN102068417A Oral drug transporting system |
| 05/25/2011 | CN102068416A Itraconazole-containing oral solid preparation and preparation method thereof |
| 05/25/2011 | CN102068413A 比阿培南冻干制剂及其制备方法 Biapenem lyophilized formulation and preparation method |
| 05/25/2011 | CN102068412A Enteric targeted tilmicosin particles and preparation method thereof |
| 05/25/2011 | CN102068410A Solid preparation of ade fovird ip iv oxil liposome |
| 05/25/2011 | CN101675923B New usage of zedoary cyclic diolefine |
| 05/25/2011 | CN101664386B Enrofloxacin double emulsion for livestock and preparation method thereof |
| 05/25/2011 | CN101643721B Broad-spectrum safe anti influenza A virus vaccine for animals |
| 05/25/2011 | CN101637471B Application of 3-fluorin-5-(trifluoromethyl)-N-(2-(1-piperidyl) ethyl) benzamide hydrochloride in the preparation of medicine and feed for resisting H5N1 type avian influenza virus |
| 05/25/2011 | CN101601666B Radix wikstroemae extractive and preparation method and application thereof |
| 05/25/2011 | CN101579426B Medicine for treating tinea manus and pedis |
| 05/25/2011 | CN101570543B Preparation method of mezlocillin sodium solvent crystal |
| 05/25/2011 | CN101564537B 3, 5-dihydroxy-4-isopropyl diphenyl ethylene-ethyl bromoacetate-polyoxyethylene compound and synthetic method thereof |
| 05/25/2011 | CN101543601B Compound pharmaceutical composition for preventing and curing respiratory diseases in animals and preparation method thereof |
| 05/25/2011 | CN101537059B Anti-enteritis canine parvovirus Chinese medicinal composition and preparation method and applications thereof |
| 05/25/2011 | CN101513506B Medicament for treating tinea manus and pedis |
| 05/25/2011 | CN101502653B Medicament composition for preventing or treating Streptococcus suis disease |
| 05/25/2011 | CN101491527B Use of tetrahydropyridines in preparing medicine for treating hepatitis or hepatocirrhosis |
| 05/25/2011 | CN101461879B Plaster for treating neck, spine, protrusion of lumbar vertebral disc, hyperosteogeny, arthralgia and myalgia |
| 05/25/2011 | CN101455729B Kangfulingshuan medicine production technique |
| 05/25/2011 | CN101417128B Preparation of BCG vaccine polysaccharide nucleic acid -DDA adjuvant and use thereof |
| 05/25/2011 | CN101328169B Diethylcarbamyl-substituted thiazole dihydropyrimidine |
| 05/25/2011 | CN101265296B Reptile cathelicidin antibiotic peptide and derivatives, and application thereof |
| 05/25/2011 | CN101229291B Chinese traditional medicine composition for treating virus hepatitis by immunoregulation |
| 05/25/2011 | CN101204416B Argillaceous medicine for sting wart |
| 05/25/2011 | CN101194995B Proprietary Chinese medicine for treating animal virus, bacterium and mix infection |
| 05/25/2011 | CN101068793B Potassium salt of an HIV integrase inhibitor |
| 05/25/2011 | CN101061109B Novel pyridonecarboxylic acid derivatives or salts thereof |
| 05/25/2011 | CN101028356B Antiseptic anti-inflammatory and its production |
| 05/25/2011 | CN101007169B A microcapsule of egg yolk immunoglobulin, preparing process and use thereof |
| 05/24/2011 | US7947720 3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| 05/24/2011 | US7947709 Non-nucleoside reverse transcriptase inhibitors |
| 05/24/2011 | US7947684 anticoagulants; immunomoderators; antiinflammatory agents |
| 05/24/2011 | US7947674 Meso-substituted porphyrins |
| 05/24/2011 | US7947291 Modified surface antigen |
| 05/24/2011 | US7947281 Chimeric proteins that induce effects directed against viruses |
| 05/24/2011 | CA2585253C Antimicrobial 2-deoxystreptamine compounds |
| 05/24/2011 | CA2537066C Benzoquinolizine-2-carboxylic acid arginine salt tetrahydrate |
| 05/24/2011 | CA2497569C 2,3-dihydro-6-nitroimidazo[2,1-b]oxazole compound |
| 05/24/2011 | CA2493764C Improved treatment of cancer with glutamine |
| 05/24/2011 | CA2477601C 5-phenylthiazole derivatives and use as pi3 kinase inhibitors |
| 05/24/2011 | CA2443952C Heteroaryl ureas containing nitrogen hetero-atoms as p38 kinase inhibitors |
| 05/24/2011 | CA2420621C Microparticle compositions and methods for the manufacture thereof |
| 05/24/2011 | CA2393710C Caspase inhibitors and uses thereof |
| 05/24/2011 | CA2382840C Improved topical compositions containing probiotic bacteria, spores, and extracellular products and uses thereof |
| 05/24/2011 | CA2374215C New mutational profiles in hiv-1 reverse transcriptase correlated with phenotypic drug resistance |
| 05/24/2011 | CA2345277C Methods for isolation, quantification, characterization and modulation of antigen-specific t cells |
| 05/24/2011 | CA2264258C Novel antimicrobial peptide |
| 05/24/2011 | CA2184890C Peptides for inducing cytotoxic t lymphocyte responses to hepatitis c virus |
| 05/19/2011 | WO2011060199A1 Boron-containing small molecules |
| 05/19/2011 | WO2011059950A1 Actinobacillus suis antigens |
| 05/19/2011 | WO2011059887A1 Hepatitis c virus inhibitors |
| 05/19/2011 | WO2011059021A1 8-azabicyclo[3.2.1]octane-8-carboxamide derivative |
| 05/19/2011 | WO2011058988A1 Antiviral agent-supporting sheet and method for producing same |
| 05/19/2011 | WO2011058964A1 Virus-inactivating agent |
| 05/19/2011 | WO2011058923A1 Antibacterial agent for drug-resistant bacteria, method for screening for same, and use of same |
| 05/19/2011 | WO2011058764A1 Gargle preparation, and process and apparatus for production of same |
| 05/19/2011 | WO2011058582A1 Histone deacetylase inhibitors for the treatment of fungal infections |
| 05/19/2011 | WO2011058346A1 Treatment of microbial infections |
| 05/19/2011 | WO2011058302A1 Bacteremia-associated antigen from staphylococcus aureus |
| 05/19/2011 | WO2011058210A1 Formulations of cationic lipoamino acids with lower haemolytic power based on the formation of catanionic pairs |
| 05/19/2011 | WO2011058183A1 Par-1 antagonists for use in the treatment or prevention of influenza virus type a infections |
| 05/19/2011 | WO2011058110A1 Quinoline and quinoxaline derivatives as kinase inhibitors |
| 05/19/2011 | WO2011057504A1 Use of variable lymphocyte receptor (vlr) of agnatha in medicament preparation |
| 05/19/2011 | WO2011036561A3 Process |
| 05/19/2011 | WO2011007961A3 Immunostimulatory compositions comprising liposome-encapsulated oligonucleotides and epitpoes |
| 05/19/2011 | WO2011006158A3 Targeting nad biosynthesis in bacterial pathogens |
| 05/19/2011 | WO2011005044A3 Novel strain of streptomyces sporoclivatus which suppresses ginseng root rot |
| 05/19/2011 | WO2011003018A3 Halogenated 2-deoxy-lactones, 2'-deoxy--nucleosides, and derivatives thereof |
| 05/19/2011 | WO2011002836A3 Attenuated enterohemorrhagic e.coli-based vaccine vector and methods relating thereto |
| 05/19/2011 | WO2010110914A3 Mammalian genes involved in infection |
| 05/19/2011 | WO2009135179A3 The use of solid carrier particles to improve the processability of a pharmaceutical agent |
| 05/19/2011 | US20110119774 Compositions of aquatic origin for prevention of cell adhesion and methods of using same |
| 05/19/2011 | US20110118354 Cyclohexenyl modulators of chemokine receptor activity |